This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In United States

AnxietyDrugFrom 55 Years to 90 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Anxiety

View study

CompletedNCT05823753

Cannabidiol to Reduce Anxiety Reactivity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Anxiety

View study

CompletedNCT02504151

Cannabidiol Treatment in people with Early Psychosis

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

View study

CompletedNCT00588731

Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

View study

CompletedNCT04192370

Cannabidiol Use to Reduce Cravings in Individuals With Addiction on Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Addiction

View study

CompletedNCT02069366

Cannabinoid Control of Fear Extinction Neural Circuits in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 21 Years to 45 Years

Countries: United States
Sponsor: Wayne State University
Condition: PTSD

View study

CompletedNCT02911324

Cannabinoid Medication for Adults With OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.